Acyl phosphonate inhibitors of β-lactamases
    1.
    发明授权
    Acyl phosphonate inhibitors of β-lactamases 失效
    β-内酰胺酶的酰基膦酸酯抑制剂

    公开(公告)号:US07205285B2

    公开(公告)日:2007-04-17

    申请号:US10628649

    申请日:2003-07-28

    IPC分类号: A61K31/66 C07F9/02

    摘要: The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic β-lactamase inhibitors presently available, and which do not possess a β-lactam pharmacophore. These new inhibitors are fully synthetic, allowing ready access to a wide variety of structurally related analogs. Certain embodiments of these new inhibitors also bind bacterial DD-peptidases, thus potentially acting both as β-lactamase inhibitors and as antibiotics.

    摘要翻译: 本发明提供了新型β-内酰胺酶抑制剂,其在结构上与目前可获得的天然产物和半合成β-内酰胺酶抑制剂无关,并且不具有β-内酰胺药效团。 这些新的抑制剂是完全合成的,可以方便地访问各种结构相关的类似物。 这些新抑制剂的某些实施方案也结合细菌DD-肽酶,因此潜在地作为β-内酰胺酶抑制剂和抗生素起作用。

    6.beta.-Bromo penicillanic acid
    3.
    发明授权
    6.beta.-Bromo penicillanic acid 失效
    6β-溴青霉烷酸

    公开(公告)号:US4180506A

    公开(公告)日:1979-12-25

    申请号:US870398

    申请日:1978-01-18

    申请人: Rex Pratt

    发明人: Rex Pratt

    CPC分类号: C07D499/00 A61K31/43

    摘要: 6.beta.-Bromo penicillanic acid is a novel compound which is an antibacterial agent as well as a potent .beta.-lactamase inhibitor.

    摘要翻译: 6β-溴青霉烷酸是一种新型化合物,其是抗菌剂以及有效的β-内酰胺酶抑制剂。

    Acyl phosphonate inhibitors of beta-lactamases
    4.
    发明申请
    Acyl phosphonate inhibitors of beta-lactamases 失效
    β-内酰胺酶的酰基膦酸酯抑制剂

    公开(公告)号:US20050119233A1

    公开(公告)日:2005-06-02

    申请号:US10628649

    申请日:2003-07-28

    摘要: The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic β-lactamase inhibitors presently available, and which do not possess a β-lactam pharmacophore. These new inhibitors are fully synthetic, allowing ready access to a wide variety of structurally related analogs. Certain embodiments of these new inhibitors also bind bacterial DD-peptidases, thus potentially acting both as β-lactamase inhibitors and as antibiotics.

    摘要翻译: 本发明提供了新型β-内酰胺酶抑制剂,其在结构上与目前可获得的天然产物和半合成β-内酰胺酶抑制剂无关,并且不具有β-内酰胺药效团。 这些新的抑制剂是完全合成的,可以方便地访问各种结构相关的类似物。 这些新抑制剂的某些实施方案也结合细菌DD-肽酶,因此潜在地作为β-内酰胺酶抑制剂和抗生素起作用。

    &bgr;-lactamase and DD-peptidase inhibitors
    5.
    发明授权
    &bgr;-lactamase and DD-peptidase inhibitors 失效
    β-内酰胺酶和DD-肽酶抑制剂

    公开(公告)号:US06608046B1

    公开(公告)日:2003-08-19

    申请号:US09582255

    申请日:2000-09-01

    IPC分类号: A61K31661

    摘要: The invention provides novel &bgr;-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic &bgr;-lactamase inhibitors presently available, and which do not possess &bgr;-lactam pharmacophore. These new inhibitors are fully synthetic, allowing ready access to a wide variety of structurally related analogs. Certain embodiments of these new inhibitors also bind bacterial DD-peptidases, thus potentially acting both as &bgr;-lactamase inhibitors and as antibiotics.

    摘要翻译: 本发明提供新颖的β-内酰胺酶抑制剂,其在结构上与目前可获得的天然产物和半合成β-内酰胺酶抑制剂无关,并且不具有β-内酰胺药效团。 这些新的抑制剂是完全合成的,可以方便地访问各种结构相关的类似物。 这些新抑制剂的某些实施方案也结合细菌DD-肽酶,因此潜在地作为β-内酰胺酶抑制剂和抗生素起作用。